0 followers
Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.
Hugo Cabrera
NMD Pharma
4 followers
Tessera Therapeutics
2 followers
Septerna
2 followers
89bio
2 followers
Neogene Therapeutics
2 followers
Protein Metrics
2 followers
SolarBioTech
2 followers
Queen Mary University
5 followers
Isotopen Technologien München
1 follower
MassBio
1 follower
Capricor Therapeutics
1 follower
Explore companies